|
| Cell type/goal | Source | Disease | Phase | Trail number |
|
| Oligodendrocyte progenitor cell | Human brain | Demyelinating diseases | Unknown | NCT00283023 |
| Human ESC-derived neural precursor cells | Human embryonic stem cells | Parkinson’s disease | Phase 2 | NCT03119636 |
| Development of iPSCs | Somatic cells of patients with neurological diseases | Neurodegenerative disorders | Recruiting | NCT00874783 |
| Generate disease-specific iPSC lines | Neuro-degenerative disease patients | Neuro-degenerative disease | Recruiting | NCT03322306 |
| Establishing of neuronal-like cells from iPSCs | PBMCs | Peripheral nervous system diseases | Withdrawn (lack of funding) | NCT02492360 |
| Neurons and glia derived from iPSCs | Patients with genetic mutations responsible for neurological and neurodegenerative diseases | Neurodegenerative diseases | Not yet recruiting | NCT03682458 |
| Develop human iPSCs | An existing collection of human somatic cells | Amyotrophic lateral sclerosis | Recruiting | NCT00801333 |
| Establishment of human cellular disease models from iPSCs | Patient-derived fibroblasts | Wilson disease | Recruiting | NCT03867526 |
| Neuronal distinction of iPSC | Human fibroblast with MYT1L mutation | Mental retardation | Completed | NCT02980302 |
| Neuronal progenitors derived from iPSC | Blood sample | Rare intellectual disabilities | Recruiting | NCT03635294 |
| Neural cells derived from iPSC | Patients’ skin | Niemann-pick diseases | Recruiting | NCT03883750 |
| Establish an iPSC bank | Patients with NF1 mutations | Tumors in the central nervous system | Suspended | NCT03332030 |
| Derivation of iPSC | Human somatic cells from existing collections | Amyotrophic lateral sclerosis | Recruiting | NCT00801333 |
| Creation of a large repository of iPSC | Blood and spinal fluid (optional) | Amyotrophic lateral sclerosis | Completed | NCT02574390 |
| Creation of a Bank of Fibroblast from iPSC | Skin biopsy | Amyotrophic lateral sclerosis | Completed | NCT01639391 |
| Development of iPSC | Patients’ fibroblast | Neurodegenerative disorders | Recruiting | NCT00874783 |
|